<!-- KEYWORD_LINKING_METADATA:
{
  "processed_timestamp": "2025-09-24T14:41:53.231710",
  "vocabulary_version": "1.0",
  "selected_keywords": [
    "Fragment-Based Drug Discovery",
    "FragmentGPT",
    "Reward Ranked Alignment with Expert Exploration",
    "Supervised Fine-Tuning",
    "Energy-Based Bond Cleavage"
  ],
  "rejected_keywords": [],
  "similarity_scores": {
    "Fragment-Based Drug Discovery": 0.78,
    "FragmentGPT": 0.81,
    "Reward Ranked Alignment with Expert Exploration": 0.77,
    "Supervised Fine-Tuning": 0.8,
    "Energy-Based Bond Cleavage": 0.75
  },
  "extraction_method": "AI_prompt_based",
  "budget_applied": true,
  "candidates_json": {
    "candidates": [
      {
        "surface": "Fragment-Based Drug Discovery",
        "canonical": "Fragment-Based Drug Discovery",
        "aliases": [
          "FBDD"
        ],
        "category": "unique_technical",
        "rationale": "This is a specialized approach in drug development that connects well with molecular design and synthesis.",
        "novelty_score": 0.75,
        "connectivity_score": 0.68,
        "specificity_score": 0.85,
        "link_intent_score": 0.78
      },
      {
        "surface": "FragmentGPT",
        "canonical": "FragmentGPT",
        "aliases": [],
        "category": "unique_technical",
        "rationale": "As a novel model, it represents a specific technological advancement in molecular design.",
        "novelty_score": 0.82,
        "connectivity_score": 0.65,
        "specificity_score": 0.88,
        "link_intent_score": 0.81
      },
      {
        "surface": "Reward Ranked Alignment with Expert Exploration",
        "canonical": "Reward Ranked Alignment with Expert Exploration",
        "aliases": [
          "RAE"
        ],
        "category": "unique_technical",
        "rationale": "This algorithm is central to the paper's methodology, linking to optimization and learning strategies.",
        "novelty_score": 0.78,
        "connectivity_score": 0.7,
        "specificity_score": 0.82,
        "link_intent_score": 0.77
      },
      {
        "surface": "Supervised Fine-Tuning",
        "canonical": "Supervised Fine-Tuning",
        "aliases": [
          "SFT"
        ],
        "category": "specific_connectable",
        "rationale": "It is a critical process in aligning models with specific goals, relevant across machine learning applications.",
        "novelty_score": 0.55,
        "connectivity_score": 0.85,
        "specificity_score": 0.65,
        "link_intent_score": 0.8
      },
      {
        "surface": "chemically-aware, energy-based bond cleavage",
        "canonical": "Energy-Based Bond Cleavage",
        "aliases": [],
        "category": "unique_technical",
        "rationale": "This technique is a novel approach in the paper, crucial for molecular manipulation.",
        "novelty_score": 0.8,
        "connectivity_score": 0.6,
        "specificity_score": 0.86,
        "link_intent_score": 0.75
      }
    ],
    "ban_list_suggestions": [
      "method",
      "experiment",
      "performance"
    ]
  },
  "decisions": [
    {
      "candidate_surface": "Fragment-Based Drug Discovery",
      "resolved_canonical": "Fragment-Based Drug Discovery",
      "decision": "linked",
      "scores": {
        "novelty": 0.75,
        "connectivity": 0.68,
        "specificity": 0.85,
        "link_intent": 0.78
      }
    },
    {
      "candidate_surface": "FragmentGPT",
      "resolved_canonical": "FragmentGPT",
      "decision": "linked",
      "scores": {
        "novelty": 0.82,
        "connectivity": 0.65,
        "specificity": 0.88,
        "link_intent": 0.81
      }
    },
    {
      "candidate_surface": "Reward Ranked Alignment with Expert Exploration",
      "resolved_canonical": "Reward Ranked Alignment with Expert Exploration",
      "decision": "linked",
      "scores": {
        "novelty": 0.78,
        "connectivity": 0.7,
        "specificity": 0.82,
        "link_intent": 0.77
      }
    },
    {
      "candidate_surface": "Supervised Fine-Tuning",
      "resolved_canonical": "Supervised Fine-Tuning",
      "decision": "linked",
      "scores": {
        "novelty": 0.55,
        "connectivity": 0.85,
        "specificity": 0.65,
        "link_intent": 0.8
      }
    },
    {
      "candidate_surface": "chemically-aware, energy-based bond cleavage",
      "resolved_canonical": "Energy-Based Bond Cleavage",
      "decision": "linked",
      "scores": {
        "novelty": 0.8,
        "connectivity": 0.6,
        "specificity": 0.86,
        "link_intent": 0.75
      }
    }
  ]
}
-->

# FragmentGPT: A Unified GPT Model for Fragment Growing, Linking, and Merging in Molecular Design

## ğŸ“‹ ë©”íƒ€ë°ì´í„°

**Links**: [[daily_digest_20250924|20250924]] [[categories/cs.AI|cs.AI]]
**PDF**: [Download](https://arxiv.org/pdf/2509.11044.pdf)
**Category**: cs.AI
**Published**: 2025-09-24
**ArXiv ID**: [2509.11044](https://arxiv.org/abs/2509.11044)

## ğŸ”— ìœ ì‚¬í•œ ë…¼ë¬¸
- [[2025-09-22/FragmentRetro_ A Quadratic Retrosynthetic Method Based on Fragmentation Algorithms_20250922|FragmentRetro: A Quadratic Retrosynthetic Method Based on Fragmentation Algorithms]] (83.6% similar)
- [[2025-09-23/Test-Time Training Scaling Laws for Chemical Exploration in Drug Design_20250923|Test-Time Training Scaling Laws for Chemical Exploration in Drug Design]] (81.9% similar)
- [[2025-09-22/Monte Carlo Tree Diffusion with Multiple Experts for Protein Design_20250922|Monte Carlo Tree Diffusion with Multiple Experts for Protein Design]] (80.3% similar)
- [[2025-09-23/Guided Sequence-Structure Generative Modeling for Iterative Antibody Optimization_20250923|Guided Sequence-Structure Generative Modeling for Iterative Antibody Optimization]] (80.1% similar)
- [[2025-09-18/Structure-Aware Contrastive Learning with Fine-Grained Binding Representations for Drug Discovery_20250918|Structure-Aware Contrastive Learning with Fine-Grained Binding Representations for Drug Discovery]] (80.0% similar)

## ğŸ·ï¸ ì¹´í…Œê³ ë¦¬í™”ëœ í‚¤ì›Œë“œ
**ğŸ”— Specific Connectable**: [[keywords/Supervised Fine-Tuning|Supervised Fine-Tuning]]
**âš¡ Unique Technical**: [[keywords/Fragment-Based Drug Discovery|Fragment-Based Drug Discovery]], [[keywords/FragmentGPT|FragmentGPT]], [[keywords/Reward Ranked Alignment with Expert Exploration|Reward Ranked Alignment with Expert Exploration]], [[keywords/Energy-Based Bond Cleavage|Energy-Based Bond Cleavage]]

## ğŸ“‹ ì €ì ì •ë³´

**Authors:** 

## ğŸ“„ Abstract (ì›ë¬¸)

arXiv:2509.11044v2 Announce Type: replace-cross 
Abstract: Fragment-Based Drug Discovery (FBDD) is a popular approach in early drug development, but designing effective linkers to combine disconnected molecular fragments into chemically and pharmacologically viable candidates remains challenging. Further complexity arises when fragments contain structural redundancies, like duplicate rings, which cannot be addressed by simply adding or removing atoms or bonds. To address these challenges in a unified framework, we introduce FragmentGPT, which integrates two core components: (1) a novel chemically-aware, energy-based bond cleavage pre-training strategy that equips the GPT-based model with fragment growing, linking, and merging capabilities, and (2) a novel Reward Ranked Alignment with Expert Exploration (RAE) algorithm that combines expert imitation learning for diversity enhancement, data selection and augmentation for Pareto and composite score optimality, and Supervised Fine-Tuning (SFT) to align the learner policy with multi-objective goals. Conditioned on fragment pairs, FragmentGPT generates linkers that connect diverse molecular subunits while simultaneously optimizing for multiple pharmaceutical goals. It also learns to resolve structural redundancies-such as duplicated fragments-through intelligent merging, enabling the synthesis of optimized molecules. FragmentGPT facilitates controlled, goal-driven molecular assembly. Experiments and ablation studies on real-world cancer datasets demonstrate its ability to generate chemically valid, high-quality molecules tailored for downstream drug discovery tasks.

## ğŸ“ ìš”ì•½

Fragment-Based Drug Discovery(FBDD)ì˜ í•œê³„ë¥¼ ê·¹ë³µí•˜ê¸° ìœ„í•´ FragmentGPTë¥¼ ì œì•ˆí•©ë‹ˆë‹¤. ì´ ëª¨ë¸ì€ ë‘ ê°€ì§€ í•µì‹¬ ìš”ì†Œë¥¼ í†µí•©í•©ë‹ˆë‹¤. ì²«ì§¸, í™”í•™ì  ì¸ì‹ì„ ê¸°ë°˜ìœ¼ë¡œ í•œ ì—ë„ˆì§€ ê¸°ë°˜ ê²°í•© ì ˆë‹¨ ì‚¬ì „ í•™ìŠµ ì „ëµì„ í†µí•´ ë¶„ì ì¡°ê°ì˜ ì„±ì¥, ì—°ê²° ë° ë³‘í•© ëŠ¥ë ¥ì„ ê°•í™”í•©ë‹ˆë‹¤. ë‘˜ì§¸, ë³´ìƒ ìˆœìœ„ ì •ë ¬ ë° ì „ë¬¸ê°€ íƒìƒ‰(RAE) ì•Œê³ ë¦¬ì¦˜ì„ í™œìš©í•˜ì—¬ ë‹¤ì–‘ì„±ì„ ë†’ì´ê³ , ë°ì´í„° ì„ íƒ ë° ì¦ê°•ì„ í†µí•´ ìµœì ì˜ ì„±ê³¼ë¥¼ ë‹¬ì„±í•©ë‹ˆë‹¤. FragmentGPTëŠ” ë‹¤ì–‘í•œ ë¶„ì í•˜ìœ„ ë‹¨ìœ„ë¥¼ ì—°ê²°í•˜ëŠ” ë§ì»¤ë¥¼ ìƒì„±í•˜ë©°, ì¤‘ë³µëœ êµ¬ì¡°ë¥¼ ì§€ëŠ¥ì ìœ¼ë¡œ ë³‘í•©í•˜ì—¬ ìµœì í™”ëœ ë¶„ìë¥¼ í•©ì„±í•©ë‹ˆë‹¤. ì‹¤ì œ ì•” ë°ì´í„°ì…‹ ì‹¤í—˜ì—ì„œ í™”í•™ì ìœ¼ë¡œ ìœ íš¨í•˜ê³  ê³ í’ˆì§ˆì˜ ë¶„ìë¥¼ ìƒì„±í•˜ì—¬ ì•½ë¬¼ ë°œê²¬ ì‘ì—…ì— ê¸°ì—¬í•  ìˆ˜ ìˆìŒì„ ì…ì¦í–ˆìŠµë‹ˆë‹¤.

## ğŸ¯ ì£¼ìš” í¬ì¸íŠ¸

- 1. Fragment-Based Drug Discovery(FBDD)ì—ì„œ íš¨ê³¼ì ì¸ ë§ì»¤ ì„¤ê³„ì˜ ì–´ë ¤ì›€ì„ í•´ê²°í•˜ê¸° ìœ„í•´ FragmentGPTë¥¼ ì†Œê°œí•©ë‹ˆë‹¤.
- 2. FragmentGPTëŠ” í™”í•™ì  ì¸ì‹ê³¼ ì—ë„ˆì§€ ê¸°ë°˜ì˜ ê²°í•© ì ˆë‹¨ ì‚¬ì „ í•™ìŠµ ì „ëµì„ í†µí•´ ë¶„ì ì¡°ê°ì˜ ì„±ì¥, ì—°ê²° ë° ë³‘í•© ê¸°ëŠ¥ì„ ì œê³µí•©ë‹ˆë‹¤.
- 3. Reward Ranked Alignment with Expert Exploration(RAE) ì•Œê³ ë¦¬ì¦˜ì„ í†µí•´ ë‹¤ëª©ì  ëª©í‘œì— ë§ì¶˜ í•™ìŠµì ì •ì±… ì •ë ¬ì„ ê°€ëŠ¥í•˜ê²Œ í•©ë‹ˆë‹¤.
- 4. FragmentGPTëŠ” ë‹¤ì–‘í•œ ë¶„ì í•˜ìœ„ ë‹¨ìœ„ë¥¼ ì—°ê²°í•˜ëŠ” ë§ì»¤ë¥¼ ìƒì„±í•˜ë©°, ë™ì‹œì— ì—¬ëŸ¬ ì œì•½ ëª©í‘œë¥¼ ìµœì í™”í•©ë‹ˆë‹¤.
- 5. ì‹¤ì œ ì•” ë°ì´í„°ì…‹ ì‹¤í—˜ì„ í†µí•´ í™”í•™ì ìœ¼ë¡œ ìœ íš¨í•˜ê³  ê³ í’ˆì§ˆì˜ ë¶„ìë¥¼ ìƒì„±í•  ìˆ˜ ìˆìŒì„ ì…ì¦í•˜ì˜€ìŠµë‹ˆë‹¤.


---

*Generated on 2025-09-24 14:41:53*